Arrowpoint Investment Partners (Singapore) Pte. Ltd.
Position in ABBV — AbbVie Inc.
CIK 2032331
SINGAPORE, U0
Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$3,001,561
+$1,164,959 QoQ
Shares Held
11,928
+48.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.92%
of 13F equity value
Holder Rank
#1,651
of 4,153 holders
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Derivatives in ABBV
reported options exposure · as of Sep 30, 2025CallValue
$2,037,552
CallShares
8,800
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Arrowpoint Investment Partners (Singapore) Pte. Ltd. holds $7,535,126 across 3 Drug Manufacturers - General names. ABBV ranks #2 (39.8% of the industry book) .
All Filings in ABBV
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,001,561 | 11,928 | Shares | Defined | 2026-08-13 | |
| 2025-12-31 | $1,836,602 | 8,038 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $2,037,552 | 8,800 | Call | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||